Complementary Enantioselective Pathways

Complementary Enantioselective Pathways is a biocatalytic strategy in stereoselective synthesis wherein two enantiocomplementary enzymes or catalytic routes selectively produce opposing enantiomers of a chiral molecule, thereby enabling access to both enantiomeric forms from the same substrate or reaction system.

16

Publications

674

Citations

52

Authors

20

Institutions

Publications per year

2017–2026

5

Authors

52

  1. DW
    David W. Knight

    Cardiff University, United Kingdom

    2 publications · 67 citations

    2

    h-index

  2. CP
    Christopher P. Morley

    SUNY Upstate Medical University, United States

    2 publications · 67 citations

    2

    h-index

  3. AC
    Andrew C. Share

    GlaxoSmithKline (United Kingdom), United Kingdom

    2 publications · 67 citations

    2

    h-index

  4. BS
    Bradford Sullivan

    Brock University, Canada

    1 publications · 36 citations

    1

    h-index

  5. RF
    Roger F. Newton

    Portsmouth College, United Kingdom

    1 publications · 12 citations

    1

    h-index

1–5 of 52

Venues

  1. Tetrahedron Letters

    2 publications · 60 citations

    2

    h-index

  2. Organic Letters

    OL · 2 publications · 65 citations

    2

    h-index

  3. 2

    h-index

  4. Tetrahedron Asymmetry

    2 publications · 59 citations

    2

    h-index

  5. Journal of the American Chemical Society

    JACS · 2 publications · 263 citations

    2

    h-index

1–5